Table of Contents
Issues Related to the Development of Drugs for the Treatment of Patients with Vascular Dementia (VaD)
Is VaD Clearly Definable Clinically?
Is VaD Clearly Definable Clinically?
Is VaD Clearly Definable Clinically?
Is VaD Clearly Definable Clinically?
Is VaD Clearly Definable Clinically?
Is VaD distinguishable from AD?
Is VaD distinguishable from AD?
Is VaD distinguishable from AD?
Outcome Measures in the Design of VaD Clinical Drug Trials
Other Features in the Design of VaD Clinical Drug Trials
Conclusions
Conclusions
Conclusions
|